210 related articles for article (PubMed ID: 6588972)
21. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
[TBL] [Abstract][Full Text] [Related]
22. Redistribution of apolipoproteins C removed from human very low density lipoprotein during in vitro lipolysis by lipoprotein lipase.
Glangeaud-Freudenthal MC; Burdin J; Ayrault-Jarrier M; Polonovski J
Biochimie; 1981 Jun; 63(6):485-94. PubMed ID: 7260173
[TBL] [Abstract][Full Text] [Related]
23. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
[TBL] [Abstract][Full Text] [Related]
24. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
25. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
26. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro.
Jahn CE; Osborne JC; Schaefer EJ; Brewer HB
Eur J Biochem; 1983 Mar; 131(1):25-9. PubMed ID: 6403350
[No Abstract] [Full Text] [Related]
27. Lipolysis-induced degradation of apolipoproteins B and E of human very low density lipoproteins.
Chung BH; Im JH; Bowdon HR
J Biol Chem; 1986 Feb; 261(6):2960-7. PubMed ID: 3949755
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart.
Tam SP; Breckenridge WC
J Lipid Res; 1983 Oct; 24(10):1343-57. PubMed ID: 6644185
[TBL] [Abstract][Full Text] [Related]
29. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
[TBL] [Abstract][Full Text] [Related]
30. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang CS; McConathy WJ; Kloer HU; Alaupovic P
J Clin Invest; 1985 Feb; 75(2):384-90. PubMed ID: 3973011
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
32. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.
Hiukka A; Fruchart-Najib J; Leinonen E; Hilden H; Fruchart JC; Taskinen MR
Diabetologia; 2005 Jun; 48(6):1207-15. PubMed ID: 15864534
[TBL] [Abstract][Full Text] [Related]
33. Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue.
Ekman R; Nilsson-Ehle P
Clin Chim Acta; 1975 Aug; 63(1):29-35. PubMed ID: 170020
[TBL] [Abstract][Full Text] [Related]
34. Lipolytic remnants of human VLDL produced in vitro. Effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants.
Chung BH; Dashti N
J Lipid Res; 2000 Feb; 41(2):285-97. PubMed ID: 10681413
[TBL] [Abstract][Full Text] [Related]
35. Induction of milk lipolysis by lipoprotein components of bovine blood serum.
Sundheim G; Zimmer TL; Astrup HN
J Dairy Sci; 1983 Mar; 66(3):400-6. PubMed ID: 6841744
[TBL] [Abstract][Full Text] [Related]
36. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.
Matsuoka N; Shirai K; Johnson JD; Kashyap ML; Srivastava LS; Yamamura T; Yamamoto A; Saito Y; Kumagai A; Jackson RL
Metabolism; 1981 Aug; 30(8):818-24. PubMed ID: 6894960
[No Abstract] [Full Text] [Related]
37. Changes with aging in serum lipoproteins and apolipoprotein C subclasses.
Takeuchi N; Matsumoto A; Katayama Y; Arao M; Koga M; Nakao H; Uchida K
Arch Gerontol Geriatr; 1983 Jul; 2(1-2):41-8. PubMed ID: 6578706
[TBL] [Abstract][Full Text] [Related]
38. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
Forte TM; Nichols AV; Krauss RM; Norum RA
J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
[TBL] [Abstract][Full Text] [Related]
39. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages.
Lindqvist P; Ostlund-Lindqvist AM; Witztum JL; Steinberg D; Little JA
J Biol Chem; 1983 Aug; 258(15):9086-92. PubMed ID: 6874679
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
